NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
CHA University
CHA University
Centre Oscar Lambret
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana